Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo

Extracorporeal shock wave therapy (ESWT) has been shown to improve symptoms in patients with interstitial cystitis/bladder pain syndrome (IC/BPS); however, there is a lack of objective evidence. We measured change of urinary biomarker levels in 25 patients with IC/BPS received ESWT or placebo once a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yuan-Chi, Tyagi, Pradeep, Lee, Wei-Chia, Chancellor, Michael, Chuang, Yao-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024394/
https://www.ncbi.nlm.nih.gov/pubmed/33824389
http://dx.doi.org/10.1038/s41598-021-87040-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024394/
https://www.ncbi.nlm.nih.gov/pubmed/33824389
http://dx.doi.org/10.1038/s41598-021-87040-1

Ejemplares similares